Lettre à l'éditeur ("European Journal of Nuclear Medicine and Molecular Imaging" 45(8) : 1463–1464https://link.springer.com/article/10.1007%2Fs00259-018-4005-4
-
July 2018 (v1)PublicationUploaded on: December 4, 2022
-
July 2018 (v1)Journal article
International audience
Uploaded on: February 22, 2023 -
July 2018 (v1)Journal article
International audience
Uploaded on: December 4, 2022 -
September 1, 2024 (v1)Journal article
Total metabolic tumor volume (TMTV) is prognostic in lymphoma. However, cutoff values for risk stratification vary markedly, according to the tumor delineation method used. We aimed to create a standardized TMTV benchmark dataset allowing TMTV to be tested and applied as a reproducible biomarker. Methods: Sixty baseline 18F-FDG PET/CT scans...
Uploaded on: January 13, 2025 -
October 21, 2024 (v1)Journal article
Classic Hodgkin lymphoma (HL) is a distinct entity among hematological malignancies of B-cell origin. It is characterized by its unique histopathological features and generally favorable prognosis. Over the years, advancements in understanding its pathogenesis, coupled with refined diagnostic and evaluation modalities, as well as therapeutic...
Uploaded on: January 13, 2025